£107.27

Springer - Targeted Drug Strategies for Cancer and Inflammation

Price data last checked 89 day(s) ago - refreshing...

View at Amazon

We'll watch every seller, every day. One email when your price arrives.

It has never been this cheap. We have no record of a lower price.

£107 today · cheaper than every other day in the last 3 months

NEW HERE?

Amazon shows you one price. We show you all of them.

Tosheroon watches Amazon prices so you don't have to. Every product on Amazon has a price history — we make it visible. Set the price you'd actually pay, and we'll email you the second it gets there. No app, no account, one email.

WHAT'S ON THIS PAGE

↓ Price chart
when this has been cheap or pricey
↓ Forecast
where the price is heading next
↓ Statistics
all-time high & low, recent range
↑ Price alert
name your number, we'll email you

Price History & Forecast

Grey patches = out of stock. Cheaper = lower on the chart. Hover for exact prices.

Last 2 days • 2 data points (No recent data available)

Historical
Generating forecast...
£107.27 £101.91 £104.05 £106.20 £108.34 £110.49 £112.63 23 February 2026 23 February 2026 23 February 2026 23 February 2026 24 February 2026

Price Distribution

Price distribution over 2 days • 1 price levels

Days at Price
2 days 0 1 1 2 2 £107 Days at Price

Price Analysis

Most common price: £107 (2 days, 100.0%)

Price range: £107 - £107

Price levels: 1 different prices over 2 days

Description

Explore the complex science of folate pathways and their role in metabolism and macromolecule synthesis with this professional resource from Springer. This text examines how antifolate drugs function, specifically focusing on those transported via the high capacity folate transporter, such as the reduced-folate carrier. Readers will gain insight into the mechanisms of dihydrofolate reductase inhibitors like methotrexate, as well as thymidylate synthase inhibitors including raltitrexed and pemetrexed. The content covers major medical advances from the last decade, such as the clinical approval of pemetrexed for treating mesothelioma and lung cancer. Additionally, the book discusses the scientific demonstration of how cell membrane-anchored folate receptors (FR) can be utilized in drug targeting. This book serves as a specialized resource for those studying oncology and the biochemical processes involved in cancer and inflammation treatments.

Key Features

Covers essential folate pathways used in metabolism and macromolecule synthesis.

Provides detailed information on antifolate drugs and their transport via the reduced-folate carrier.

Analyzes specific inhibitors including methotrexate, raltitrexed, and pemetrexed.

Discusses recent medical advances regarding pemetrexed for lung cancer and mesothelioma treatment.

Explains the role of cell membrane-anchored folate receptors in targeted drug strategies.

Product Specifications

Format
paperback
Domain
Amazon UK
Release Date
01 October 2014
Listed Since
01 October 2014

Barcode

No barcode data available